{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:25:34Z","timestamp":1786119934063,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1097\/fpc.0b013e32834910d1","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T14:21:06Z","timestamp":1309011666000},"page":"587-589","source":"Crossref","is-referenced-by-count":10,"title":["Regulation of ocular adrenoceptor genes expression by 5-MCA-NAT"],"prefix":"10.1097","volume":"21","author":[{"given":"Almudena","family":"Crooke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Huete-Toral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Mart\u00ednez-\u00c1guila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Alarma-Estrany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Pintor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210213","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/sj.bjp.0705118","article-title":"Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor.","volume":"138","author":"Pintor","year":"2003","journal-title":"Br J Pharmacol"},{"key":"R2-9-20210213","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-079X.2009.00702.x","article-title":"5-MCA-NAT does not act through NQO2 to reduce IOP in New Zealand white rabbit.","volume":"47","author":"Alarma-Estrany","year":"2009","journal-title":"J Pineal Res"},{"key":"R3-9-20210213","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-079X.2010.00746.x","article-title":"Molecular and cellular pharmacological properties of 5-methoxycarbonylamino-N-acetyltryptamine (MCA-NAT): a nonspecific MT3 ligand.","volume":"48","author":"Vincent","year":"2010","journal-title":"J Pineal Res"},{"key":"R4-9-20210213","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.autneu.2007.07.004","article-title":"Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT.","volume":"137","author":"Alarma-Estrany","year":"2007","journal-title":"Auton Neurosci"},{"key":"R5-9-20210213","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1515\/REVNEURO.2004.15.3.209","article-title":"Genetic aspects of melatonin biology.","volume":"15","author":"Anisimov","year":"2004","journal-title":"Rev Neurosci"},{"key":"R6-9-20210213","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1007\/PL00012498","article-title":"Melatonin regulation of antioxidant enzyme gene expression.","volume":"59","author":"Mayo","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"R7-9-20210213","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.exer.2008.10.018","article-title":"Measurement of aqueous humor flow.","volume":"88","author":"McLaren","year":"2009","journal-title":"Exp Eye Res"},{"key":"R8-9-20210213","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method.","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"R9-9-20210213","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1213\/ane.0b013e3181907ebe","article-title":"Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure, and promotes better operating conditions during cataract surgery under topical anesthesia.","volume":"108","author":"Ismail","year":"2009","journal-title":"Anesth Analg"},{"key":"R10-9-20210213","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.ijg.0000133150.44686.0b","article-title":"Effect of 5-MCA-NAT, a putative melatonin MT3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes.","volume":"13","author":"Serle","year":"2004","journal-title":"J Glaucoma"},{"key":"R11-9-20210213","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2007.04.020","article-title":"Hypotensive effect of profilin on rabbit IOP.","volume":"567","author":"Morales","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"R12-9-20210213","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1017\/S0952523807070605","article-title":"Localization of alpha 2 receptors in ocular tissues.","volume":"24","author":"Woldemussie","year":"2007","journal-title":"Vis Neurosci"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01213011-201109000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:30:21Z","timestamp":1786044621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01213011-201109000-00009"}},"subtitle":["implications for glaucoma treatment"],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e32834910d1","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}